Zipfel PA - Search Results

1

Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review.

Steinhoff BJ, Klein P, Klitgaard H, Laloyaux C, Moseley BD, Ricchetti-Masterson K, Rosenow F, Sirven JI, Smith B, Stern JM, Toledo M, Zipfel PA, Villanueva V. Steinhoff BJ, et al. Among authors: zipfel pa. Epilepsy Behav. 2021 May;118:107939. doi: 10.1016/j.yebeh.2021.107939. Epub 2021 Apr 8. Epilepsy Behav. 2021. PMID: 33839453 Free article. Review.

2

Enhancing melanoma treatment with resveratrol.

Osmond GW, Augustine CK, Zipfel PA, Padussis J, Tyler DS. Osmond GW, et al. Among authors: zipfel pa. J Surg Res. 2012 Jan;172(1):109-15. doi: 10.1016/j.jss.2010.07.033. Epub 2010 Aug 6. J Surg Res. 2012. PMID: 20855085

3

Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy.

Augustine CK, Toshimitsu H, Jung SH, Zipfel PA, Yoo JS, Yoshimoto Y, Selim MA, Burchette J, Beasley GM, McMahon N, Padussis J, Pruitt SK, Ali-Osman F, Tyler DS. Augustine CK, et al. Among authors: zipfel pa. Mol Cancer Ther. 2010 Jul;9(7):2090-101. doi: 10.1158/1535-7163.MCT-10-0073. Epub 2010 Jun 22. Mol Cancer Ther. 2010. PMID: 20571072

4

Ral activation promotes melanomagenesis.

Zipfel PA, Brady DC, Kashatus DF, Ancrile BD, Tyler DS, Counter CM. Zipfel PA, et al. Oncogene. 2010 Aug 26;29(34):4859-64. doi: 10.1038/onc.2010.224. Epub 2010 Jun 21. Oncogene. 2010. PMID: 20562921 Free PMC article.

5

Genomic and molecular profiling predicts response to temozolomide in melanoma.

Augustine CK, Yoo JS, Potti A, Yoshimoto Y, Zipfel PA, Friedman HS, Nevins JR, Ali-Osman F, Tyler DS. Augustine CK, et al. Among authors: zipfel pa. Clin Cancer Res. 2009 Jan 15;15(2):502-10. doi: 10.1158/1078-0432.CCR-08-1916. Clin Cancer Res. 2009. PMID: 19147755

6

Novel anticancer compounds induce apoptosis in melanoma cells.

Bhat UG, Zipfel PA, Tyler DS, Gartel AL. Bhat UG, et al. Among authors: zipfel pa. Cell Cycle. 2008 Jun 15;7(12):1851-5. doi: 10.4161/cc.7.12.6032. Epub 2008 Jun 30. Cell Cycle. 2008. PMID: 18583930

7

Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment.

Augustine CK, Yoshimoto Y, Gupta M, Zipfel PA, Selim MA, Febbo P, Pendergast AM, Peters WP, Tyler DS. Augustine CK, et al. Among authors: zipfel pa. Cancer Res. 2008 May 15;68(10):3777-84. doi: 10.1158/0008-5472.CAN-07-5949. Cancer Res. 2008. PMID: 18483261

8

Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.

Jung JH, Pendergast AM, Zipfel PA, Traugh JA. Jung JH, et al. Among authors: zipfel pa. Biochemistry. 2008 Jan 22;47(3):1094-104. doi: 10.1021/bi701533j. Epub 2007 Dec 28. Biochemistry. 2008. PMID: 18161990

9

Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents.

Yoshimoto Y, Augustine CK, Yoo JS, Zipfel PA, Selim MA, Pruitt SK, Friedman HS, Ali-Osman F, Tyler DS. Yoshimoto Y, et al. Among authors: zipfel pa. Mol Cancer Ther. 2007 May;6(5):1492-500. doi: 10.1158/1535-7163.MCT-06-0718. Epub 2007 May 4. Mol Cancer Ther. 2007. PMID: 17483437

10

Role for the Abi/wave protein complex in T cell receptor-mediated proliferation and cytoskeletal remodeling.

Zipfel PA, Bunnell SC, Witherow DS, Gu JJ, Chislock EM, Ring C, Pendergast AM. Zipfel PA, et al. Curr Biol. 2006 Jan 10;16(1):35-46. doi: 10.1016/j.cub.2005.12.024. Curr Biol. 2006. PMID: 16401422 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page